当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

  

流通市值:65.37亿  总市值:66.49亿
流通股本:12.87亿   总股本:13.09亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金23,954,906,028.5611,168,439,682.9856,225,650,992.5938,024,329,190.39
  收到的税费返还--11,072,232.76-
  收到其他与经营活动有关的现金78,103,694.17816,533,656.17349,299,958.551,166,791,695.72
  经营活动现金流入小计24,033,009,722.7311,984,973,339.1556,586,023,183.939,191,120,886.11
  购买商品、接受劳务支付的现金26,548,798,231.7414,888,756,059.8251,301,372,909.6939,771,817,559.85
  支付给职工以及为职工支付的现金530,465,484.25316,652,576.08978,903,680.85830,823,264.52
  支付的各项税费499,428,560.39271,568,974.91,017,753,815.05777,824,373.05
  支付其他与经营活动有关的现金485,797,186.73108,434,853.751,152,227,362.91704,487,458.28
  经营活动现金流出小计28,064,489,463.1115,585,412,464.5554,450,257,768.542,084,952,655.7
  经营活动产生的现金流量净额-4,031,479,740.38-3,600,439,125.42,135,765,415.4-2,893,831,769.59
二、投资活动产生的现金流量:
  收回投资收到的现金827,000,000---
  取得投资收益收到的现金1,929,902.12690,965.483,342,990.322,030,763.2
  处置固定资产、无形资产和其他长期资产收回的现金净额6,987,749.35279,461.487,091,022.14,860,572.39
  投资活动现金流入小计835,917,651.47970,426.9610,434,012.426,891,335.59
  购建固定资产、无形资产和其他长期资产支付的现金140,494,57167,566,651.24544,760,104.06478,600,439.59
  投资支付的现金909,000,000-27,600,00025,200,000
  支付其他与投资活动有关的现金-340,000,000--
  投资活动现金流出小计1,049,494,571407,566,651.24572,360,104.06503,800,439.59
  投资活动产生的现金流量净额-213,576,919.53-406,596,224.28-561,926,091.64-496,909,104
三、筹资活动产生的现金流量:
  吸收投资收到的现金33,007,745-76,718,200735,000
  其中:子公司吸收少数股东投资收到的现金33,007,745-76,718,200735,000
  取得借款收到的现金10,854,009,962.086,363,293,333.3416,602,282,765.4112,187,038,200.86
  发行债券收到的现金4,072,528,735.851,000,000,0004,499,887,5003,999,887,500
  收到其他与筹资活动有关的现金39,406,7401,072,528,735.85--
  筹资活动现金流入小计14,998,953,182.938,435,822,069.1921,178,888,465.4116,187,660,700.86
  偿还债务支付的现金11,435,874,062.15,492,282,857.2521,282,875,173.9613,544,614,661.48
  分配股利、利润或偿付利息支付的现金433,594,400.09138,936,694.1617,744,311.24546,882,284.52
  其中:子公司支付给少数股东的股利、利润61,287,650.74-112,919,162.8484,511,040.35
  支付其他与筹资活动有关的现金132,351,136.4923,820,688.23118,040,978.2896,181,379.93
  筹资活动现金流出小计12,001,819,598.685,655,040,239.5822,018,660,463.4814,187,678,325.93
  筹资活动产生的现金流量净额2,997,133,584.252,780,781,829.61-839,771,998.071,999,982,374.93
五、现金及现金等价物净增加额-1,247,923,075.66-1,226,253,520.07734,067,325.69-1,390,758,498.66
  加:期初现金及现金等价物余额2,928,136,456.552,928,136,456.552,194,069,130.862,194,069,130.86
  期末现金及现金等价物余额1,680,213,380.891,701,882,936.482,928,136,456.55803,310,632.2
补充资料:
  净利润379,749,529.44-743,119,993.89-
  资产减值准备3,827,050.29-18,267,214.45-
  固定资产和投资性房地产折旧65,052,348.09-121,628,563.95-
  无形资产摊销16,951,279.85-32,395,107.97-
  长期待摊费用摊销10,094,817.03-16,549,417.6-
  处置固定资产、无形资产和其他长期资产的损失-8,651,959.87--3,852,284.16-
  固定资产报废损失152,490.76---
  公允价值变动损失-383,768.34---
  财务费用144,985,507.7-326,276,767.48-
  投资损失1,476,139.27--4,018,269.49-
  递延所得税-17,984,015.96--21,232,042.7-
  其中:递延所得税资产减少-18,525,961.89--20,464,353.97-
    递延所得税负债增加541,945.93--767,688.73-
  存货的减少125,974,414.8--502,369,276.16-
  经营性应收项目的减少-4,839,595,497.73-454,046,005.51-
  经营性应付项目的增加-54,651,329.85-790,191,969.63-
  现金的期末余额1,680,213,380.89-2,928,136,456.55-
  减:现金的期初余额2,928,136,456.55-2,194,069,130.86-
  现金及现金等价物的净增加额-1,247,923,075.66-734,067,325.69-
公告日期2025-08-302025-04-302025-04-102024-10-31
审计意见(境内)标准无保留意见
TOP↑